PAB 16.7% 0.4¢ patrys limited

Ann: PAT-DX1 Targets and Kills Brain Cancer Stem Cells, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,316 Posts.
    lightbulb Created with Sketch. 168
    I had an order in that did not get filled - grr should not have been such a tight arse...

    This is huge as results based on human stem cells and not mouse model studies as per previous results.
    ----------------------------
    "Drs. James Hansen and Jiangbing Zhou of the Yale School of Medicine have confirmed that PAT‐DX1 and PAT‐DX1‐NP target tumor spheres derived from human glioblastoma cancer stem cells (CSCs). "

    This is going to explode today
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.